Regeneron Pharmaceuticals (REGN)
R&D to Revenue
38.03%
Quarterly · Period ending:
REGN R&D to Revenue
Latest reported38.03%period ending
Latest reported38.03%period ending
REGN Quarterly R&D/Revenue (0.00% → 38.03%)
Latest values, visible window
High-resolution chart · PNG
REGN r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 339.0898% | |
| 184.9752% | |
| 81.3041% | |
| 94.4922% | |
| 99.6818% | |
| 114.0693% | |
| 83.1933% | |
| 114.1593% | |
| 183.0508% | |
| 203.6364% | |
| 133.7838% | |
| 91.6667% | |
| 67.4074% | |
| 126.1538% | |
| 61.4035% | |
| 76.4045% | |
| 104.5455% | |
| 114.5161% | |
| 106.1538% | |
| 124.1935% | |
| 109.6774% | |
| 132.6923% | |
| 103.4483% | |
| 91.9355% | |
| 76.3158% | |
| 84.058% | |
| 118.1818% | |
| 106.7416% | |
| 286.1111% | |
| 360% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |